[8-K] Hamilton Lane Incorporated Reports Material Event
Hamilton Lane Incorporated reported an underwriting agreement related to an offering of Class A Common Stock. The filing summarizes customary representations, warranties and indemnification provisions in the Underwriting Agreement and discloses a contractual restriction preventing the company, HLA and a selling stockholder from selling or transferring Class A Common Stock or securities convertible into Class A Common Stock for 45 days after September 2, 2025 without the underwriter's written consent. The offering was made under an effective shelf registration (File No. 333-283233) and a prospectus supplement dated September 2, 2025. The company filed the Underwriting Agreement as Exhibit 1.1 and counsel opinion of Simpson Thacher & Bartlett LLP as Exhibit 5.1.
Hamilton Lane Incorporated ha comunicato un accordo di sottoscrizione relativo a un鈥檕fferta di Azioni Ordinarie di Classe A. Il documento riassume le consuete rappresentazioni, garanzie e disposizioni di indennizzo previste dall鈥橴nderwriting Agreement e dichiara una limitazione contrattuale che impedisce alla societ脿, a HLA e a un azionista venditore di vendere o trasferire Azioni Ordinarie di Classe A o titoli convertibili in tali azioni per 45 giorni dopo il 2 settembre 2025 senza il consenso scritto del sottoscrittore. L鈥檕fferta 猫 stata effettuata ai sensi di una registrazione shelf efficace (File No. 333-283233) e di un supplemento al prospetto datato 2 settembre 2025. La societ脿 ha depositato l鈥橴nderwriting Agreement come Exhibit 1.1 e il parere legale di Simpson Thacher & Bartlett LLP come Exhibit 5.1.
Hamilton Lane Incorporated inform贸 un acuerdo de suscripci贸n relacionado con una oferta de Acciones Ordinarias Clase A. La presentaci贸n resume las habituales declaraciones, garant铆as y disposiciones de indemnizaci贸n del Acuerdo de Suscripci贸n y revela una restricci贸n contractual que impide a la compa帽铆a, a HLA y a un accionista vendedor vender o transferir Acciones Ordinarias Clase A o valores convertibles en dichas acciones durante 45 d铆as despu茅s del 2 de septiembre de 2025 sin el consentimiento por escrito del suscriptor. La oferta se realiz贸 bajo un registro shelf efectivo (File No. 333-283233) y un suplemento de prospecto fechado el 2 de septiembre de 2025. La compa帽铆a present贸 el Acuerdo de Suscripci贸n como Exhibit 1.1 y el dictamen legal de Simpson Thacher & Bartlett LLP como Exhibit 5.1.
Hamilton Lane Incorporated電� 韥措灅鞀� A 氤错喌欤� 氚滍枆瓿� 甏�霠悳 鞚胳垬瓿勳暯鞚� 氤搓碃頄堨姷雼堧嫟. 鞝滌稖靹滊電� 鞚胳垬瓿勳暯靹滌棎 韽暔霅� 韱奠儊鞝侅澑 歆勳垹路氤挫 氚� 氅挫眳 臁绊暛鞚� 鞖旍暯頃橁碃 鞛堨溂氅�, 須岇偓鞕� HLA 氚� 毵る弰欤检＜臧� 鞚胳垬鞚胳潣 靹滊┐ 霃欖潣 鞐嗢澊 2025雲� 9鞗� 2鞚� 鞚错泟 45鞚缄皠 韥措灅鞀� A 氤错喌欤� 霕愲姅 韥措灅鞀� A 氤错喌欤茧 鞝勴櫂 臧�電ロ暅 歃濌秾鞚� 毵り皝頃橁卑雮� 鞏戨弰頃橃 氇豁晿霃勲 頃橂姅 瓿勳暯靸� 鞝滍暅鞚� 瓿奠嫓頃橁碃 鞛堨姷雼堧嫟. 頃措嫻 氚滍枆鞚� 鞙犿毃頃� 靺疙攧 霌彪(File No. 333-283233)瓿� 2025雲� 9鞗� 2鞚�鞛� 韴瀽靹る獏靹� 氤挫订鞛愲鞐� 霐半澕 鞚措（鞏挫鞀惦媹雼�. 須岇偓電� 鞚胳垬瓿勳暯鞚� Exhibit 1.1搿�, Simpson Thacher & Bartlett LLP鞚� 氩曤 鞚橁铂靹滊ゼ Exhibit 5.1搿� 鞝滌稖頄堨姷雼堧嫟.
Hamilton Lane Incorporated a d茅clar茅 un contrat de souscription relatif 脿 une offre d鈥檃ctions ordinaires de cat茅gorie A. Le dossier r茅sume les d茅clarations, garanties et dispositions d鈥檌ndemnisation usuelles pr茅vues par l鈥橴nderwriting Agreement et divulgue une restriction contractuelle emp锚chant la soci茅t茅, HLA et un actionnaire vendeur de vendre ou transf茅rer des actions ordinaires de cat茅gorie A ou des titres convertibles en ces actions pendant 45 jours apr猫s le 2 septembre 2025 sans le consentement 茅crit du souscripteur. L鈥檕ffre a 茅t茅 r茅alis茅e dans le cadre d鈥檜n enregistrement shelf effectif (File No. 333-283233) et d鈥檜n suppl茅ment de prospectus dat茅 du 2 septembre 2025. La soci茅t茅 a d茅pos茅 l鈥橴nderwriting Agreement en tant qu鈥橢xhibit 1.1 et l鈥檃vis juridique de Simpson Thacher & Bartlett LLP en tant qu鈥橢xhibit 5.1.
Hamilton Lane Incorporated meldete einen 脺bernahmevertrag im Zusammenhang mit einem Angebot von Class-A-Stammaktien. Die Einreichung fasst die 眉blichen Zusicherungen, Garantien und Entsch盲digungsregelungen des Underwriting Agreement zusammen und offenbart eine vertragliche Beschr盲nkung, die das Unternehmen, HLA und einen ver盲u脽ernden Aktion盲r daran hindert, Class-A-Stammaktien oder in solche Aktien wandelbare Wertpapiere f眉r 45 Tage nach dem 2. September 2025 ohne schriftliche Zustimmung des Underwriters zu verkaufen oder zu 眉bertragen. Das Angebot erfolgte unter einem wirksamen Shelf-Registration (File No. 333-283233) und einem Prospektzusatz vom 2. September 2025. Das Unternehmen reichte das Underwriting Agreement als Exhibit 1.1 und die Stellungnahme der Kanzlei Simpson Thacher & Bartlett LLP als Exhibit 5.1 ein.
- Underwriting Agreement disclosed with customary representations, warranties and indemnification provisions
- 45-day transfer restriction on sales by the company, HLA and a selling stockholder is explicitly disclosed
- Offering executed under an effective shelf registration (File No. 333-283233) with a prospectus supplement dated September 2, 2025
- Counsel opinion filed as Exhibit 5.1 (Simpson Thacher & Bartlett LLP) and Underwriting Agreement filed as Exhibit 1.1
- None.
Insights
TL;DR: Company executed an underwritten offering under an existing shelf with a standard 45-day lock-up; legal opinion and exhibits were filed.
The disclosure describes an underwritten sale of Class A Common Stock made pursuant to an effective shelf registration statement and a prospectus supplement dated September 2, 2025. The Underwriting Agreement contains customary representations, warranties and indemnities and imposes a 45-day resale restriction for the company, HLA and a selling stockholder. Exhibits filed include the Underwriting Agreement (Exhibit 1.1) and counsel opinion (Exhibit 5.1). From a market-disclosure perspective, this is a routine transactional filing providing legal and contractual details rather than financial results.
TL;DR: Governance disclosure covers indemnities and a short lock-up; filings of key exhibits bolster transparency.
The Form 8-K describes the material terms of an underwriting arrangement and explicitly references indemnification provisions and a 45-day restriction on sales by specified parties. The filing also incorporates the shelf registration and prospectus supplement by reference and attaches the counsel opinion as an exhibit, which supports legal sufficiency of the offering documentation. The disclosure focuses on contractual and compliance elements rather than operational or financial changes.
Hamilton Lane Incorporated ha comunicato un accordo di sottoscrizione relativo a un鈥檕fferta di Azioni Ordinarie di Classe A. Il documento riassume le consuete rappresentazioni, garanzie e disposizioni di indennizzo previste dall鈥橴nderwriting Agreement e dichiara una limitazione contrattuale che impedisce alla societ脿, a HLA e a un azionista venditore di vendere o trasferire Azioni Ordinarie di Classe A o titoli convertibili in tali azioni per 45 giorni dopo il 2 settembre 2025 senza il consenso scritto del sottoscrittore. L鈥檕fferta 猫 stata effettuata ai sensi di una registrazione shelf efficace (File No. 333-283233) e di un supplemento al prospetto datato 2 settembre 2025. La societ脿 ha depositato l鈥橴nderwriting Agreement come Exhibit 1.1 e il parere legale di Simpson Thacher & Bartlett LLP come Exhibit 5.1.
Hamilton Lane Incorporated inform贸 un acuerdo de suscripci贸n relacionado con una oferta de Acciones Ordinarias Clase A. La presentaci贸n resume las habituales declaraciones, garant铆as y disposiciones de indemnizaci贸n del Acuerdo de Suscripci贸n y revela una restricci贸n contractual que impide a la compa帽铆a, a HLA y a un accionista vendedor vender o transferir Acciones Ordinarias Clase A o valores convertibles en dichas acciones durante 45 d铆as despu茅s del 2 de septiembre de 2025 sin el consentimiento por escrito del suscriptor. La oferta se realiz贸 bajo un registro shelf efectivo (File No. 333-283233) y un suplemento de prospecto fechado el 2 de septiembre de 2025. La compa帽铆a present贸 el Acuerdo de Suscripci贸n como Exhibit 1.1 y el dictamen legal de Simpson Thacher & Bartlett LLP como Exhibit 5.1.
Hamilton Lane Incorporated電� 韥措灅鞀� A 氤错喌欤� 氚滍枆瓿� 甏�霠悳 鞚胳垬瓿勳暯鞚� 氤搓碃頄堨姷雼堧嫟. 鞝滌稖靹滊電� 鞚胳垬瓿勳暯靹滌棎 韽暔霅� 韱奠儊鞝侅澑 歆勳垹路氤挫 氚� 氅挫眳 臁绊暛鞚� 鞖旍暯頃橁碃 鞛堨溂氅�, 須岇偓鞕� HLA 氚� 毵る弰欤检＜臧� 鞚胳垬鞚胳潣 靹滊┐ 霃欖潣 鞐嗢澊 2025雲� 9鞗� 2鞚� 鞚错泟 45鞚缄皠 韥措灅鞀� A 氤错喌欤� 霕愲姅 韥措灅鞀� A 氤错喌欤茧 鞝勴櫂 臧�電ロ暅 歃濌秾鞚� 毵り皝頃橁卑雮� 鞏戨弰頃橃 氇豁晿霃勲 頃橂姅 瓿勳暯靸� 鞝滍暅鞚� 瓿奠嫓頃橁碃 鞛堨姷雼堧嫟. 頃措嫻 氚滍枆鞚� 鞙犿毃頃� 靺疙攧 霌彪(File No. 333-283233)瓿� 2025雲� 9鞗� 2鞚�鞛� 韴瀽靹る獏靹� 氤挫订鞛愲鞐� 霐半澕 鞚措（鞏挫鞀惦媹雼�. 須岇偓電� 鞚胳垬瓿勳暯鞚� Exhibit 1.1搿�, Simpson Thacher & Bartlett LLP鞚� 氩曤 鞚橁铂靹滊ゼ Exhibit 5.1搿� 鞝滌稖頄堨姷雼堧嫟.
Hamilton Lane Incorporated a d茅clar茅 un contrat de souscription relatif 脿 une offre d鈥檃ctions ordinaires de cat茅gorie A. Le dossier r茅sume les d茅clarations, garanties et dispositions d鈥檌ndemnisation usuelles pr茅vues par l鈥橴nderwriting Agreement et divulgue une restriction contractuelle emp锚chant la soci茅t茅, HLA et un actionnaire vendeur de vendre ou transf茅rer des actions ordinaires de cat茅gorie A ou des titres convertibles en ces actions pendant 45 jours apr猫s le 2 septembre 2025 sans le consentement 茅crit du souscripteur. L鈥檕ffre a 茅t茅 r茅alis茅e dans le cadre d鈥檜n enregistrement shelf effectif (File No. 333-283233) et d鈥檜n suppl茅ment de prospectus dat茅 du 2 septembre 2025. La soci茅t茅 a d茅pos茅 l鈥橴nderwriting Agreement en tant qu鈥橢xhibit 1.1 et l鈥檃vis juridique de Simpson Thacher & Bartlett LLP en tant qu鈥橢xhibit 5.1.
Hamilton Lane Incorporated meldete einen 脺bernahmevertrag im Zusammenhang mit einem Angebot von Class-A-Stammaktien. Die Einreichung fasst die 眉blichen Zusicherungen, Garantien und Entsch盲digungsregelungen des Underwriting Agreement zusammen und offenbart eine vertragliche Beschr盲nkung, die das Unternehmen, HLA und einen ver盲u脽ernden Aktion盲r daran hindert, Class-A-Stammaktien oder in solche Aktien wandelbare Wertpapiere f眉r 45 Tage nach dem 2. September 2025 ohne schriftliche Zustimmung des Underwriters zu verkaufen oder zu 眉bertragen. Das Angebot erfolgte unter einem wirksamen Shelf-Registration (File No. 333-283233) und einem Prospektzusatz vom 2. September 2025. Das Unternehmen reichte das Underwriting Agreement als Exhibit 1.1 und die Stellungnahme der Kanzlei Simpson Thacher & Bartlett LLP als Exhibit 5.1 ein.
FAQ
What did Hamilton Lane (HLNE) disclose in this 8-K?
How long is the resale restriction following the offering?
Under what registration was the offering made?
Where can I find the Underwriting Agreement and legal opinion?
Does the 8-K disclose financial results or changes to operations?
